MBS: NextGenPCR workflow detects omicron variant of SARS-CoV-2

GOES, Netherlands, Jan. 6, 2022 /PRNewswire/ — Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that both in silico and bench testing confirmed that the NextGenPCR PCR reagents detected the omicron variant of SARS-CoV-2. The testing demonstrated similar…